ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials-Reference-Cited by-同舟云学术

ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials

Published:2012-05-10 Issue:2 Volume:1 Page:111-126
ISSN:2073-4409
Container-title:Cells
language:en
Short-container-title:Cells

Author:

Malyguine Anatoli M.,Strobl Susan,Dunham Kimberly,Shurin Michael R.,Sayers Thomas J.

Publisher

MDPI AG

Subject

General Medicine

Link

http://www.mdpi.com/2073-4409/1/2/111/pdf

Reference63 articles.

1. Phenotypic Analysis of Antigen-Specific T Lymphocytes

2. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

3. Functional heterogeneity of vaccine-induced CD8(+) T cells;Monsurro;J. Immunol.,2002

4. A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for hla class i-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients;Scheibenbogen;Clin. Cancer Res.,1997

5. Analysis of the T cell response to tumor and viral peptide antigens by an IFNγ-ELISPOT assay

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective and Successful Quantification of Leukemia-Specific Immune Cells in AML Patients’ Blood or Culture, Focusing on Intracellular Cytokine and Degranulation Assays;International Journal of Molecular Sciences;2024-06-26

2. A single-cell characterised signature integrating heterogeneity and microenvironment of lung adenocarcinoma for prognostic stratification;eBioMedicine;2024-04

3. Immunospot Assessment of T-Cell Responses in Preclinical Tumor Models with Undefined Target Antigens;Methods in Molecular Biology;2024

4. Assessing Antigen-Specific T Cell Responses Through IFN-γ Enzyme-Linked Immune Absorbent Spot (ELISpot);Methods in Molecular Biology;2024

5. The Applications of ELISpot in the Identification and Treatment of Various Forms of Tuberculosis and in the Cancer Immunotherapies;Methods in Molecular Biology;2024